• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Indoco Remedies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532612
INE873D01024
119.0842677
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDOCO
96.89
2083.75
EPS(TTM)
Face Value()
Div & Yield %
2.33
2
0.09
 

MSTC consolidated net profit rises 2.26% in the March 2026 quarter
Jun 01,2026
Net profit of MSTC rose 2.26% to Rs 77.22 crore in the quarter ended March 2026 as against Rs 75.51 crore during the previous quarter ended March 2025. Sales rose 33.71% to Rs 118.80 crore in the quarter ended March 2026 as against Rs 88.85 crore during the previous quarter ended March 2025.

For the full year,net profit declined 46.34% to Rs 218.43 crore in the year ended March 2026 as against Rs 407.07 crore during the previous year ended March 2025. Sales rose 18.88% to Rs 369.66 crore in the year ended March 2026 as against Rs 310.96 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales118.8088.85 34 369.66310.96 19
OPM %63.9359.47 -59.3657.09 -
PBDT107.5276.02 41 302.80253.89 19
PBT104.8273.87 42 292.44244.80 19
NP77.2275.51 2 218.43407.07 -46